| Treister and Sroussi Awarded $3.7M National Institutes of Health Grant to Study Chronic Graft Versus Host Disease |
Treister and Sroussi Awarded $3.7M National Institutes of Health Grant to Study Chronic Graft Versus Host Diseaseby Department of Surgery at Brigham and Women’s Hospital | July 30, 2019
"Nathaniel S. Treister, DMD, DMSc and Herve Y. Sroussi, DMD, PhD, of the Division of Oral Medicine and Dentistry at Brigham and Women’s Hospital have been awarded a $3.7M National Institutes of Health (NIH) R01 Grant for their study entitled “Long-Term Oral Health Outcomes in the Chronic GVHD Consortium.” Chronic graft-versus-host disease (cGVHD) is a complex immune-mediated disease commonly seen in recipients of allogeneic hematopoietic stem cell transplantation. cGVHD can severely affect the health of numerous organ systems including the oral cavity, one of its most common and significantly affected targets. This study will explore the long-term effects of cGVHD on oral health with the ultimate goal of improving the patients’ quality of life and maximizing treatment effectiveness and outcomes. Drs. Treister and Sroussi will serve as co-principal investigators on the study which is a collaboration between the Dana-Farber/Brigham and Women’s Cancer Center and the Fred Hutchinson Cancer Research Center/University of Washington School of Dentistry in Seattle, WA." David Dean will be the Principal Investigator for the Seattle site. |
